Shanghai Kaibao Pharmaceutical Co Ltd Sustainability Reports

The company engages in the research, development, production, and sale of modern traditional Chinese medicine preparations. Its core product includes Tanreqing Injection used for treating respiratory diseases.

Sector: Manufacturing

Country: China

Exchange: Shenzhen Stock Exchange

FIGI: BBG001T65TT2

7 reports from 2017 to 2025

• Shanghai Kaibao Pharmaceutical Co Ltd 2025 Social Responsibility Report
• Shanghai Kaibao Pharmaceutical Co Ltd 2024 Corporate Responsibility Report
• Shanghai Kaibao Pharmaceutical Co Ltd 2023 Annual Social Responsibility Report
• Shanghai Kaibao Pharmaceutical Co Ltd 2022 Annual Social Responsibility Report
• Shanghai Kaibao Pharmaceutical Co Ltd 2020 Annual Social Responsibility Report